Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach

Aya Fujita, Hidetaka Yamamoto, Masakazu Imamura, Norimoto Nakamura, Yoshihiko Maehara, Masazumi Tsuneyoshi, Yoshinao Oda

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The biological behavior of gastrointestinal stromal tumors (GISTs) ranges from benign to malignant, and the risk of an adverse outcome is correlated with the location of the primary tumor, tumor size, and mitotic counts. Cell cycle regulators are potentially associated with the tumorigenesis and progression of GISTs. Checkpoint with forkhead and ring finger (CHFR) functions as an important checkpoint protein in the early to mid-prophase to regulate mitosis. In this study, we evaluated the expression of CHFR and several cell cycle regulators, including cyclin A, cyclin B1, cdc2, and cdk2, by immunohistochemical staining in 53 cases of primary gastric GISTs, and compared the immunohistochemical results with the clinicopathological factors or the GIST risk grades as modified by Miettinen et al. Of the 53 cases, 18 (34%) showed decreased nuclear CHFR expression. Decreased CHFR expression was correlated with higher mitotic counts [>5/50 high-power fields (HPFs)] (p=0.039) and a high-risk grade (p=0.0475), but not with expression of other cell cycle regulators. Higher cyclin A labeling index (LI, >1.5%), cyclin B1 LI (>0.25%), cdc2 LI (>1.16%), Ki-67 LI (>4.9%), mitotic counts (>5/50 HPF) and high-risk grade were each associated with shorter disease-free survival (p = 0.0017, p=0.003, p = 0.0471, p=0.002, p<0.001, and p=0.0017, respectively). Our results suggest that modified risk grade and increased expression of G2-M regulators such as cyclin A, cyclin B1, and cdc2 are useful for predicting the biological behavior of gastric GISTs. In addition, decreased CHFR expression may play a role in increased proliferative activity of higher grade GISTs.

Original languageEnglish
Pages (from-to)163-169
Number of pages7
JournalVirchows Archiv
Volume460
Issue number2
DOIs
Publication statusPublished - Feb 1 2012

Fingerprint

M Phase Cell Cycle Checkpoints
Gastrointestinal Stromal Tumors
Stomach
Cell Cycle
Cyclin B1
Cyclin A
Proteins
Prophase
Mitosis
Fingers
Disease-Free Survival
Neoplasms
Carcinogenesis
Staining and Labeling

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach. / Fujita, Aya; Yamamoto, Hidetaka; Imamura, Masakazu; Nakamura, Norimoto; Maehara, Yoshihiko; Tsuneyoshi, Masazumi; Oda, Yoshinao.

In: Virchows Archiv, Vol. 460, No. 2, 01.02.2012, p. 163-169.

Research output: Contribution to journalArticle

Fujita, Aya ; Yamamoto, Hidetaka ; Imamura, Masakazu ; Nakamura, Norimoto ; Maehara, Yoshihiko ; Tsuneyoshi, Masazumi ; Oda, Yoshinao. / Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach. In: Virchows Archiv. 2012 ; Vol. 460, No. 2. pp. 163-169.
@article{9b9f69d4e592499085e94b908a2f0a10,
title = "Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach",
abstract = "The biological behavior of gastrointestinal stromal tumors (GISTs) ranges from benign to malignant, and the risk of an adverse outcome is correlated with the location of the primary tumor, tumor size, and mitotic counts. Cell cycle regulators are potentially associated with the tumorigenesis and progression of GISTs. Checkpoint with forkhead and ring finger (CHFR) functions as an important checkpoint protein in the early to mid-prophase to regulate mitosis. In this study, we evaluated the expression of CHFR and several cell cycle regulators, including cyclin A, cyclin B1, cdc2, and cdk2, by immunohistochemical staining in 53 cases of primary gastric GISTs, and compared the immunohistochemical results with the clinicopathological factors or the GIST risk grades as modified by Miettinen et al. Of the 53 cases, 18 (34{\%}) showed decreased nuclear CHFR expression. Decreased CHFR expression was correlated with higher mitotic counts [>5/50 high-power fields (HPFs)] (p=0.039) and a high-risk grade (p=0.0475), but not with expression of other cell cycle regulators. Higher cyclin A labeling index (LI, >1.5{\%}), cyclin B1 LI (>0.25{\%}), cdc2 LI (>1.16{\%}), Ki-67 LI (>4.9{\%}), mitotic counts (>5/50 HPF) and high-risk grade were each associated with shorter disease-free survival (p = 0.0017, p=0.003, p = 0.0471, p=0.002, p<0.001, and p=0.0017, respectively). Our results suggest that modified risk grade and increased expression of G2-M regulators such as cyclin A, cyclin B1, and cdc2 are useful for predicting the biological behavior of gastric GISTs. In addition, decreased CHFR expression may play a role in increased proliferative activity of higher grade GISTs.",
author = "Aya Fujita and Hidetaka Yamamoto and Masakazu Imamura and Norimoto Nakamura and Yoshihiko Maehara and Masazumi Tsuneyoshi and Yoshinao Oda",
year = "2012",
month = "2",
day = "1",
doi = "10.1007/s00428-011-1181-z",
language = "English",
volume = "460",
pages = "163--169",
journal = "Virchows Archiv",
issn = "0945-6317",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach

AU - Fujita, Aya

AU - Yamamoto, Hidetaka

AU - Imamura, Masakazu

AU - Nakamura, Norimoto

AU - Maehara, Yoshihiko

AU - Tsuneyoshi, Masazumi

AU - Oda, Yoshinao

PY - 2012/2/1

Y1 - 2012/2/1

N2 - The biological behavior of gastrointestinal stromal tumors (GISTs) ranges from benign to malignant, and the risk of an adverse outcome is correlated with the location of the primary tumor, tumor size, and mitotic counts. Cell cycle regulators are potentially associated with the tumorigenesis and progression of GISTs. Checkpoint with forkhead and ring finger (CHFR) functions as an important checkpoint protein in the early to mid-prophase to regulate mitosis. In this study, we evaluated the expression of CHFR and several cell cycle regulators, including cyclin A, cyclin B1, cdc2, and cdk2, by immunohistochemical staining in 53 cases of primary gastric GISTs, and compared the immunohistochemical results with the clinicopathological factors or the GIST risk grades as modified by Miettinen et al. Of the 53 cases, 18 (34%) showed decreased nuclear CHFR expression. Decreased CHFR expression was correlated with higher mitotic counts [>5/50 high-power fields (HPFs)] (p=0.039) and a high-risk grade (p=0.0475), but not with expression of other cell cycle regulators. Higher cyclin A labeling index (LI, >1.5%), cyclin B1 LI (>0.25%), cdc2 LI (>1.16%), Ki-67 LI (>4.9%), mitotic counts (>5/50 HPF) and high-risk grade were each associated with shorter disease-free survival (p = 0.0017, p=0.003, p = 0.0471, p=0.002, p<0.001, and p=0.0017, respectively). Our results suggest that modified risk grade and increased expression of G2-M regulators such as cyclin A, cyclin B1, and cdc2 are useful for predicting the biological behavior of gastric GISTs. In addition, decreased CHFR expression may play a role in increased proliferative activity of higher grade GISTs.

AB - The biological behavior of gastrointestinal stromal tumors (GISTs) ranges from benign to malignant, and the risk of an adverse outcome is correlated with the location of the primary tumor, tumor size, and mitotic counts. Cell cycle regulators are potentially associated with the tumorigenesis and progression of GISTs. Checkpoint with forkhead and ring finger (CHFR) functions as an important checkpoint protein in the early to mid-prophase to regulate mitosis. In this study, we evaluated the expression of CHFR and several cell cycle regulators, including cyclin A, cyclin B1, cdc2, and cdk2, by immunohistochemical staining in 53 cases of primary gastric GISTs, and compared the immunohistochemical results with the clinicopathological factors or the GIST risk grades as modified by Miettinen et al. Of the 53 cases, 18 (34%) showed decreased nuclear CHFR expression. Decreased CHFR expression was correlated with higher mitotic counts [>5/50 high-power fields (HPFs)] (p=0.039) and a high-risk grade (p=0.0475), but not with expression of other cell cycle regulators. Higher cyclin A labeling index (LI, >1.5%), cyclin B1 LI (>0.25%), cdc2 LI (>1.16%), Ki-67 LI (>4.9%), mitotic counts (>5/50 HPF) and high-risk grade were each associated with shorter disease-free survival (p = 0.0017, p=0.003, p = 0.0471, p=0.002, p<0.001, and p=0.0017, respectively). Our results suggest that modified risk grade and increased expression of G2-M regulators such as cyclin A, cyclin B1, and cdc2 are useful for predicting the biological behavior of gastric GISTs. In addition, decreased CHFR expression may play a role in increased proliferative activity of higher grade GISTs.

UR - http://www.scopus.com/inward/record.url?scp=84859930948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859930948&partnerID=8YFLogxK

U2 - 10.1007/s00428-011-1181-z

DO - 10.1007/s00428-011-1181-z

M3 - Article

C2 - 22190007

AN - SCOPUS:84859930948

VL - 460

SP - 163

EP - 169

JO - Virchows Archiv

JF - Virchows Archiv

SN - 0945-6317

IS - 2

ER -